Search

Knee osteoarthritis is a chronic degenerative disease companied with chronic knee pain and dysfunction. However, the etiology and pathogenesis of knee osteoarthritis were unclear. Currently, age, diet, trauma, obesity, and inheritance are the main risk factors. The major pathological hallmarks of knee osteoarthritis included subchondral bone sclerosis, articular cartilage degeneration, arthrosynovitis, and osteophyte. With the acceleration of the aging process in China, the treatment of knee arthritis and the methods to improve the quality of life have become the focus of medical staff. Currently, therapies in clinical practice include surgery and nonoperative treatment; however, the clinical effects of different individuals at different stages will still be very different. This article reviews the recent advances in the treatment of knee osteoarthritis from three aspects: nonsurgical treatment, surgical treatment, and modern new medical means. [ABSTRACT FROM AUTHOR]

As important carriers of local innovation activities, innovative industrial clusters are attracting increasing attention. Therefore, several countries have started promotion policies for innovative industrial clusters. However, there are few empirical studies on relevant policies. This paper investigates the impact of China's "innovative industrial cluster pilot" (IICP) policy on regional innovation. Taking the implementation of IICP policy as a quasi-natural experiment and using the panel data of 266 prefecture-level cities in China in 2008-2019, this paper provides strong evidence that IICP policy promotes regional innovation. The conclusion still holds after a battery of robustness checks. The heterogeneity test shows that the promoting effect of IICP policy on innovation is more significant in central and western region than in eastern region. Moreover, the lower the city administrative level and the lower the dependence on natural resource, the more prominent the innovation effect of IICP policy. Further, the mechanism test shows that the IICP policy can promote regional innovation indirectly by strengthening government support for innovation and attracting the agglomeration of science and technological talents, but the mediation effect of industrial structure has not been verified. [ABSTRACT FROM AUTHOR]

Scylla paramamosain is one of the commercially crucial marine crustaceans belonging to the genus Scylla, which is commonly distributed along the coasts of China. Proteomic data are scarce for the mud crab. Salinity is one of the ecological factors that affect S. paramamosain during overwintering. To understand the energy metabolism mechanism adapted to salinity, we analysed the proteomics of S. paramamosain hepatopancreas in response to two different salinities (4‰ and 25‰). A total of 1283 proteins were detected, of which 426 down‐regulated proteins and 83 up‐regulated proteins were associated with metabolism (p < 0.05). Among these proteins related to metabolic pathways (16 pathways), we identified angiotensin‐converting enzyme, trypsin, glutamate dehydrogenase, aminomethyl transferase, hexokinase, pyruvate kinase, glucose‐6‐phosphate dehydrogenase, L‐lactate dehydrogenase, superoxide dismutase, alkaline phosphatase, catalase and xanthine dehydrogenases. Additionally, real‐time PCR showed mRNA expression of differentially expressed genes correlated positively with their protein levels. Compared with 25‰ salinity group, 4‰ salinity group was involved in amino acid metabolism, carbohydrate metabolism, energy metabolism, lipid metabolism and inorganic ion metabolism by regulating related proteins, which made the metabolism of the overwintering S. paramamosain more vigorous in the low salt environment, and hepatopancreas consumed more energy to maintain life activities. These data are the first to reveal the molecular mechanism of overwintering S. paramamosain in response to different salinities at the protein level. The study provides important information for the aquaculture production of S. paramamosain during indoor overwintering. [ABSTRACT FROM AUTHOR]